Hamed Afkhami | Breast cancer (BC) | Best Researcher Award

Posted on by Pencis

🏥Current Position and Roles:

Hamed Afkhami is a distinguished professional in the field of medical microbiology and bacteriology. He is currently a professor at Qom Azad University and also serves as the quality control manager of the microbiology department at Kamkar Hospital, Qom Province. His role involves ensuring laboratory excellence, supervising diagnostic workflows, and driving research into microbial pathogens.

🎓Academic Background:

Hamed’s educational journey reflects exceptional dedication:

  • Specialized Doctorate in Medical Bacteriology
    Shahid University of Medical Sciences, Tehran (1398–1403), GPA: 18/30
    Focus: Advanced bacteriology techniques, antimicrobial properties of nanostructures.
  • Master’s in Medical Microbiology
    Iran University of Medical Sciences (1394–1397), GPA: 17/25
    Thesis: Antimicrobial properties of graphene-alginate quantum dot nanocomposites.
  • Bachelor’s in Microbiology
    Qom University of Medical Sciences (1389–1393), GPA: 25.17
    Comprehensive focus on bacteriology, virology, and parasitology.

📄🖋️Publication Achievements:

Hamed has an extensive publication portfolio, including three English books published internationally on platforms like Noor, Scholar, and Amazon. Notable works include:

  1. Overview of Amyotrophic Lateral Sclerosis
  2. Manual Endoscopic Device for Human Airway Blockages
  3. Antibacterial Applications of Hydrogel Scaffolds

🌍🧪Research Articles:

His scholarly contributions focus on antimicrobial nanocomposites, stem-cell encapsulation in hydrogels, and biofilm-resistant materials. His articles have been featured in prestigious journals and presented at leading congresses like the 21st International Microbiology Congress of Iran. 🌍🧪

🔬📝Ongoing Research:

Hamed’s current research includes:

  • Investigating antimicrobial properties of Gelatin-GQD nanocomposites on burn infections caused by Pseudomonas aeruginosa.
  • Developing biofilm-resistant wound dressings utilizing mesenchymal stem cells in collagen-fibrin hydrogel scaffolds.
  • Exploring antimicrobial peptide applications for combatting Peptostreptococcus anaerobius infections in mice.

🔎🧬Research Interests: 

Hamed’s diverse research interests encompass:

  • Antimicrobial resistance mechanisms.
  • Tissue engineering using nanostructured materials.
  • Viral infections and the role of probiotics in disease prevention.
  • Innovative applications in stem cell encapsulation and biofilm inhibition.

🏛️✅Professional Associations & Tasks Completed:

  • Member of the Executive Committee for multiple scientific congresses, including the 8th, 9th, and 10th Laboratory and Clinical Congresses.
  • Conducted flow cytometry and real-time PCR workshops, emphasizing hands-on skills.
  • Supervised students for national rankings in medical sciences and bacteriology. 🌟👩‍🎓👨‍🎓

🏫🛠️Training & Workshops Conducted: 

  • ISO 15189 Workshop: Quality management in medical laboratories.
  • Essay Writing Workshops: At Azad University of Qom, fostering academic excellence in research.
  • PCR Techniques & Applications: Hands-on training in advanced molecular diagnostics.

🚀✨Success Factors: 

Hamed attributes his professional success to:

  1. Unwavering curiosity and dedication to microbial research.
  2. Strong mentorship from top researchers like Dr. Kamili and Dr. Davalit.
  3. Integration of innovative techniques such as electrospinning and stem cell-based therapy.

🧪📊Publications & Laboratory Experience:

Hamed has extensive laboratory experience, including:

  • Fabrication of tissue engineering scaffolds for wound healing.
  • Development of antibacterial hydrogels with cutting-edge nanomaterials.
  • Proficiency in diagnostic techniques such as antibiogram tests, ELISA, and flow cytometry.

🎤🔬Oral Presentations & Patents:

Hamed has delivered numerous oral presentations at congresses and holds three patents, including:

  1. A multi-channel syringe for drug delivery.
  2. An innovative antimicrobial dressing.
  3. A manual endoscopic device for airway clearance.

Citations:

Citations – 753

h-index – 14

i10-index – 2

 🌟📜Conclusion: A Remarkable Journey in Microbiology 

Hamed Afkhami exemplifies excellence in medical microbiology, with a balance of teaching, research, and clinical expertise. His contributions to nanomaterials, antimicrobial resistance, and bioengineering have advanced the field, earning recognition at national and international levels. His commitment to mentoring, innovation, and community service makes him a cornerstone of microbiological research and education. 🌍🔬

Top Notable Publications:

Investigation of CST7 and hsa-miR-4793-5p gene expression in breast cancer
Authors: Kalaki, N.S., Ahmadzadeh, M., Dehghan, M., Davoudi, S., Afkhami, H.
Year: 2024
Journal: Biochemistry and Biophysics Reports
Volume: 40
Article ID: 101863
Citations: 0

Mechanisms of resistance and decreased susceptibility to azithromycin in Shigella
Authors: Ghalavand, Z., Behruznia, P., Kodori, M., Neamati, F., Poornaki, S.M.
Year: 2024
Journal: Gene Reports
Volume: 37
Article ID: 102011
Citations: 0

Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Authors: Yarahmadi, A., Zare, M., Aghayari, M., Afkhami, H., Jafari, G.A.
Year: 2024
Journal: Cell Communication and Signaling
Volume: 22 (1)
Article ID: 239
Citations: 0

Corrigendum to “Potential antibacterial activity and healing effect of topical administration of bone marrow and adipose mesenchymal stem cells encapsulated in collagen-fibrin hydrogel scaffold on full-thickness burn wound infection caused by Pseudomonas aeruginosa”
Authors: Mirshekar, M., Afkhami, H., Razavi, S., Motaghinejad, M., Karimi, R.
Year: 2024
Journal: Burns
Volume: 50 (8)
Pages: 2141
Citations: 0

New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells
Authors: Farokhi, S., Razavi, Z.-S., Mavaei, M., Afkhami, H., Sardarabadi, H.
Year: 2024
Journal: Discover Applied Sciences
Volume: 6 (8)
Article ID: 411
Citations: 4

Bactericidal Activity of Serum by Brucella Abortus RB51 Outer Membrane Protein’s Combined by Brucella Abortus S99 Lipopolysaccharide Induction
Authors: Sisakht, B.H., Khaledi, M., Afkhami, H., Fathi, J., Sadati, M.S.
Year: 2024
Journal: Avicenna Journal of Medical Biotechnology
Volume: 16 (3)
Pages: 187–192
Citations: 0

Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection
Authors: Hassan Kalantar Neyestanaki, M., Gholizadeh, O., Hosseini Tabatabaie, F., Afkhami, H., Sedighi, S.
Year: 2024
Journal: VirusDisease
Volume: 35 (2)
Pages: 342–356
Citations: 0

Materials based on biodegradable polymers chitosan/gelatin: a review of potential applications
Authors: Yarahmadi, A., Dousti, B., Karami-Khorramabadi, M., Afkhami, H.
Year: 2024
Journal: Frontiers in Bioengineering and Biotechnology
Volume: 12
Article ID: 1397668
Citations: 2

Applications of mesenchymal stem cell-exosome components in wound infection healing: new insights
Authors: Fakouri, A., Razavi, Z.-S., Mohammed, A.T., Afkhami, H., Hooshiar, M.H.
Year: 2024
Journal: Burns and Trauma
Volume: 12
Article ID: tkae021
Citations: 8

 

Continue reading “Hamed Afkhami | Breast cancer (BC) | Best Researcher Award” →

Hayat Ullah | Pharmacology | Best Researcher Award 

Posted on by Pencis

🏥Current Position and Roles:

Dr. Hayat Ullah currently serves as a Visiting Assistant Professor in the Department of Chemistry at the University of Okara, Pakistan. His role involves lecturing in various fields of organic chemistry, mentoring students, and contributing to curriculum development. He has also previously held a position as an Assistant Professor (IPFP) at the same institution, where he was integral in course planning, student engagement, and guiding research initiatives.

🎓Academic Background:

Dr. Hayat Ullah‘s academic journey in chemistry is both extensive and focused. He completed his Ph.D. in Organic Chemistry (2014-2018) at Hazara University, Pakistan, where he explored the “Synthesis and Biological Evaluation of Thiazole, Oxadiazole, and Indole Derivatives.” Prior to this, he pursued an M.Phil. in Organic Chemistry (2012-2014) at Hazara University, focusing on the biological evaluation of thiazole derivatives. His early academic milestones include an M.Sc. in Organic Chemistry from Kohat University of Science & Technology (2005-2007) and a B.Sc. from the University of Peshawar, Pakistan (2003-2005), both achieved with distinction. Additionally, he earned a Bachelor of Education (B.Ed.) from the University of Peshawar (2009-2010), which equipped him with essential teaching skills.

🧪🔬Research Interests and Ongoing Research:

Dr. Ullah’s research focuses on bioactive compound synthesis, particularly within synthetic organic chemistry, and exploring asymmetric synthesis. He is engaged in developing innovative methodologies aimed at discovering new molecules with potential applications as anti-Alzheimer’s agents. His current project, funded with PKR 1,000,000, is a focused initiative targeting the development of acetylcholinesterase and butyrylcholinesterase inhibitors using indole-bearing oxadiazole scaffolds, which holds promise in the field of Alzheimer’s research.

📚🏆Publications and Achievements:

Throughout his career, Dr. Ullah has authored multiple scientific publications in prestigious journals, detailing his findings on bioactive compounds and their medicinal applications. His work has been well-received within the academic community, earning him the designation of HEC Approved Supervisor in 2020 by Pakistan’s Higher Education Commission (HEC). He also holds an Associate Fellowship from Advance HE, UK (2022), highlighting his contributions to higher education and pedagogy.

Notable Publications:

  • Articles focused on synthetic methodologies and biological evaluations of compounds.
  • Research outputs that align with his goals of contributing to medicinal chemistry.

📈🛠️Training & Workshops: 

Dr. Ullah has pursued extensive professional development through programs by Pakistan’s Higher Education Commission, including:

  • Startup Research Grant Program (NAHE), 2021: This grant supports emerging researchers in building a foundation for their scientific endeavors.
  • National Faculty Development Program (NAHE), 2020: A comprehensive training initiative that improved his pedagogical and research skills.
  • Fundamentals of Project Management (NAHE), 2021: Focused on enhancing project management competencies essential for academic research.
  • ACS Reviewer Lab, American Chemical Society, 2020: International training on peer-review techniques, sharpening his editorial skills in scientific publishing.

🎓📖Courses Taught:

Dr. Ullah’s teaching portfolio encompasses several specialized courses for undergraduate and postgraduate students. His courses include:

  • Organic Spectroscopy
  • Heterocyclic Chemistry
  • Fuel Chemistry
  • Research Methodology
  • Organic Synthesis
  • Environmental Chemistry

These courses reflect his broad expertise in organic chemistry and his commitment to providing a comprehensive education to his students.

🏅🎖️Scholarships and Awards:

Dr. Ullah has received numerous accolades, including grants, fellowships, and recognitions. Some of his awards are:

  • Associate Fellowship, Advance HE, UK (2022)
  • HEC Approved Supervisor (2020)
  • Startup Research Grant Program (2021)
  • National Faculty Development Program (2020)

These awards underscore his dedication to both teaching and research excellence in the field of organic chemistry.

🌍🎤Professional Associations and Presentations:

As a respected member of the academic community, Dr. Ullah has actively contributed to professional associations and academic conferences, sharing his research findings and engaging with peers. His involvement includes:

  • Oral Presentations: Delivered at national and international forums, particularly on synthetic organic chemistry.
  • Professional Associations: Regular participation in chemistry societies, fostering collaboration and knowledge-sharing with fellow researchers.

🔬⚗️Laboratory Experience:

Dr. Ullah’s hands-on experience in organic chemistry laboratories has been instrumental in his research on bioactive compounds. His laboratory skills include organic synthesis techniques, spectroscopic analysis, and bioactivity assays. This technical proficiency enables him to undertake complex synthetic chemistry projects and train students in laboratory best practices.

 Citations:

Citations: 3289

h-index:  35

i10-index:  64

🌟Conclusion: Success Factors and Impact:

Dr. Hayat Ullah’s career exemplifies a commitment to scientific advancement and education in organic chemistry. His success can be attributed to:

  • Academic Excellence: A solid educational foundation in organic chemistry and continuous professional development.
  • Research Contributions: Focused research in bioactive compounds, contributing to advancements in medicinal chemistry.
  • Teaching and Mentorship: A diverse teaching portfolio, inspiring future scientists and fostering a supportive learning environment.
  • Professional Recognition: Acknowledged through awards and certifications, highlighting his dedication to his field.

Through his teaching, research, and professional development, Dr. Ullah has made significant contributions to the field of chemistry, particularly in Pakistan’s academic landscape, and is poised to continue impacting the realms of organic and medicinal chemistry.

 

Top Notable Publications:

 

Nadeem, M.S., Hayat, S., Rahim, F., Iftikhar, S., Muhammad, K. (2025). Synthesis, biological evaluation, molecular docking and dynamic simulation of novel benzofuran derivatives as potential agents against Alzheimer’s disease. Journal of Molecular Structure, 1322, 140279.

Iqbal, T., Khan, S., Rahim, F., Alzahrani, A.Y.A., Alraih, A.M. (2025). Insights into the role of potent thiadiazole-based Schiff base derivatives in targeting type-II diabetes: A combine in-vitro and in-silico approaches. Journal of Molecular Structure, 1321, 140000.

Umar, A., Khan, M.S., Wajid, M., Ullah, H. (2024). Biocompatibility, antimicrobial efficacy, and therapeutic potential of cobalt carbonate nanoparticles in wound healing, sex hormones, and metabolic regulation in diabetic albino mice. Biochemical and Biophysical Research Communications, 734, 150773.

Alzahrani, A.Y.A., Ullah, H., Rahim, F., Iqbal, N., Nawaz, F. (2024). Synthesis, biological evaluation and in silico molecular modeling studies of chloro substituted bis-indole containing benzohydrazide analogues as potential anti-diabetic and anti-Alzheimer’s agents. Journal of Molecular Structure, 1316, 138908.

Ullah, H., Uddin, I., Ali, H.Z., Iqbal, R., Nabi, M. (2024). A promising α-glucosidase and α-amylase inhibitors based on benzimidazole-oxadiazole hybrid analogues: Evidence-based in vitro and in silico studies. Results in Chemistry, 11, 101832.

Aleid, G., Ahmad Abbasi, S., Ullah, H., Niaz, Z., Taha, M. (2024). Design, synthesis, biological evaluation and molecular docking study of thiadiazole-isatin hybrid analogues as potential anti-diabetic and anti-bacterial agents. Results in Chemistry, 11, 101805.

Amjid, Z., Khan, S., Iqbal, T., Ullah, R., Ali, E.A. (2024). Synthesis, confirmations, and biological evaluation of acid-substituted Schiff base derivatives: Unraveling insight through SAR, DFT, ADMET, and molecular docking. Results in Chemistry, 11, 101744.

Aleid, G., Imran, M., Ullah, H., Iqbal, R., Abdel-Hameed, R. (2024). Design, synthesis, in vitro bio-evaluation and in silico molecular docking study of benzohydrazide-based thiourea analogues. Results in Chemistry, 11, 101756.

Naz, H., Othman, M.S., Rahim, F., Khan, Y., Shah, S.A.A. (2024). Investigation of novel benzimidazole-based indole/thiazole hybrids derivatives as effective anti-diabetics and anti-Alzheimer’s agents: Structure-activity relationship insight, in vitro and in silico approaches. Journal of Molecular Structure, 1312, 138592.

Othman, M.S., Naz, H., Rahim, F., Iqbal, R., Adnan Ali Shah, S. (2024). New cholinesterase inhibitors based on 1,2,4-triazole bearing benzenesulfonohydrazide skeleton: Synthesis, in vitro and in silico studies. Results in Chemistry, 10, 101717.

 

 

Continue reading “Hayat Ullah | Pharmacology | Best Researcher Award “ →

Paweł Rajewski | Cardiovascular risk | Best Research Article Award | Best Research Article Award

Posted on by Pencis

🏥Current Position and Roles:

Dr. Paweł Rajewski is a distinguished medical doctor, professor, and the rector of the Faculty of Health Sciences at the University of Health Sciences in Bydgoszcz. He holds the vital role of Provincial Consultant in Infectious Diseases for the Kuyavian-Pomeranian Voivodeship, providing oversight and strategic insights on infectious disease management in the region. Dr. Rajewski serves as the Head of the Department of Internal Medicine and Infectious Diseases at the Tadeusz Browicz Provincial Infectious Disease Hospital in Bydgoszcz, as well as the Head of the Liver, Internal, Infectious, and Metabolic Disorders Clinic at CM Gizińscy in Bydgoszcz. Previously, he served as the Medical Director and Head of the Department of Internal Medicine and Hepatology at the Emil Warmiński Multispecialist City Hospital. Through these roles, he contributes to the health of countless patients while also shaping medical policy and practice.

🎓Academic Background:

Dr. Rajewski’s academic journey has been marked by an enduring commitment to medicine, specializing in areas such as internal medicine, infectious diseases, hepatology, and clinical transplantation. His qualifications in these areas form the bedrock of his clinical and academic expertise, enabling him to deliver high-impact research and patient care in fields that are central to public health. Dr. Rajewski’s education includes specialty certifications as a lipidologist, accredited by the Polish Lipid Association, and an obesitologist with certifications from the Polish Association for the Study of Obesity and the Polish Society for Obesity Treatment.

📚Research Interests and Publication Achievements: 

Dr. Rajewski has contributed over 200 articles, primarily focused on metabolic disorders, obesity, liver diseases, and cardiovascular risk factors. His work, published in reputed medical journals, has been instrumental in advancing knowledge on these critical health issues. His research sheds light on complex metabolic processes, influencing both preventive and therapeutic approaches to conditions like non-alcoholic fatty liver disease and atherosclerosis. His publications are widely recognized for their scientific rigor and relevance, contributing to his esteemed reputation in the medical research community.

🔬Ongoing Research Projects:

Dr. Rajewski is currently engaged in various research projects that address emerging concerns in metabolic health and infectious diseases. His work on liver disease mechanisms and cardiovascular risk factors associated with obesity and metabolic syndrome aims to uncover better diagnostic markers and treatment pathways. A recent focus involves studying COVID-19’s impact on liver function and the interplay between viral infections and metabolic health, topics highly relevant in today’s healthcare landscape.

👥Professional Associations and Certifications: 

Dr. Rajewski’s memberships in prestigious medical associations, including the Polish Lipid Association and the Polish Association for the Study of Obesity, underscore his dedication to staying at the forefront of medical science. His certified expertise as a lipidologist and obesitologist enables him to approach health issues with a comprehensive understanding of lipid and metabolic disorders, enhancing the efficacy of treatments and preventive measures.

🏆Scholarships and Awards: 

Dr. Rajewski’s contributions to medicine have earned him numerous accolades, recognizing his achievements in research and clinical practice. These awards celebrate his innovation in metabolic research and his pivotal role in infectious disease management. His scholarship funding reflects a legacy of excellence and a commitment to advancing medical science.

📖Training & Workshops Attended:

In his pursuit of continual growth, Dr. Rajewski has attended a series of specialized workshops on bioinformatics, advanced diagnostics, and clinical applications in infectious disease management. These workshops equip him with cutting-edge skills that he applies to his daily work, benefiting patients and enhancing the training of his medical students.

💻Contributions to Bioinformatics and Clinical Research: 

A proficient bioinformatician, Dr. Rajewski integrates data science and computational tools in his research on metabolic diseases and infectious pathogens. By utilizing bioinformatics, he has been able to analyze complex datasets, leading to insights into genetic predispositions and disease progression. His ability to harness bioinformatics tools strengthens his work in both metabolic and infectious disease studies, positioning him at the cutting edge of medical research.

🎤Oral Presentations and Conferences: 

As a frequent presenter at national and international conferences, Dr. Rajewski shares his research findings with the medical community. His presentations cover topics like liver disease pathogenesis, metabolic syndrome treatments, and emerging infectious diseases. He contributes actively to knowledge exchange, with his lectures serving as valuable learning resources for both peers and students.

📊Key Tasks and Responsibilities as a Researcher:

In his research role, Dr. Rajewski coordinates multi-disciplinary teams, designing studies, and conducting extensive data analyses. His responsibilities include overseeing clinical trials and ensuring the ethical integrity of research protocols. His dedication to stringent research standards has led to significant findings that improve patient care protocols and inform public health strategies.

🌠Success Factors:

Dr. Rajewski attributes his success to his commitment to continuous learning, innovation, and collaboration. His ability to bridge theoretical research with practical applications in healthcare makes his contributions exceptionally valuable. Additionally, his leadership in the clinical setting exemplifies his holistic approach to healthcare, balancing research with direct patient care.

🔍Publications & Laboratory Experience:

Dr. Rajewski’s extensive laboratory experience includes advanced diagnostics in liver diseases, where he employs innovative techniques to diagnose and manage conditions like hepatitis and liver fibrosis. His publications detail his findings on the effectiveness of new biomarkers, offering insights that enhance both diagnostics and treatment options for liver and metabolic disorders.

🌐Conclusion: 

Dr. Paweł Rajewski’s career exemplifies a dedication to excellence in medicine, research, and public health. His multifaceted expertise in internal medicine, infectious diseases, and metabolic health has propelled him to the forefront of healthcare in Poland. Dr. Rajewski’s contributions are invaluable to the fields of hepatology and infectious disease, positively impacting patient care and advancing medical knowledge. Through his foundation, research, and clinical roles, he continues to shape the future of health sciences, creating a lasting legacy of compassion, knowledge, and innovation.

 

Top Notable Publications:

 

Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults

Authors: Not listed; need to check for full author details.

Year: 2024

Citation: Biomedicines, 2024, 12(10), article 2400. DOI: 10.3390/biomedicines12102400.

Feasibility and Cardiometabolic Effects of Time-Restricted Eating in Patients with Metabolic Syndrome

Authors: Not listed; need to check for full author details.

Year: 2024

Citation: Nutrients, 2024, 16(12), article 1802. DOI: 10.3390/nu16121802.

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Journal of Clinical Medicine, 2022, 11(17), article 5193. DOI: 10.3390/jcm11175193.

The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Vaccines, 2022, 10(4), article 506. DOI: 10.3390/vaccines10040506.

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Journal of Clinical Medicine, 2022, 11(2), article 379. DOI: 10.3390/jcm11020379.

Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines

Authors: Not listed; need to check for full author details.

Year: 2022

Citation: Vaccines, 2022, 10(1), article 99. DOI: 10.3390/vaccines10010099.

Pilot Clinical Trial of Time-Restricted Eating in Patients with Metabolic Syndrome

Authors: Not listed; need to check for full author details.

Year: 2021

Citation: Nutrients, 2021, 13(2), article 346. DOI: 10.3390/nu13020346.

Resveratrol’s Impact on Vascular Smooth Muscle Cells Hyporeactivity: The Role of Rho-Kinase Inhibition

Authors: Not listed; need to check for full author details.

Year: 2020

Citation: BioMed Research International, 2020, article 9012071. DOI: 10.1155/2020/9012071.

Zakażenie wirusem cytomegalii w praktyce klinicznej – diagnostyka, objawy i leczenie w świetle aktualnej wiedzy

Authors: Not listed; need to check for full author details.

Year: 2019

Citation: Forum Zakażeń, 2019, issue 4, article FZ2019042. DOI: 10.15374/FZ2019042.

Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie‐Restricted Diet

Authors: Not listed; need to check for full author details.

Year: 2017

Citation: Oxidative Medicine and Cellular Longevity, 2017, article 8494107. DOI: 10.1155/2017/8494107.

Zaid Al jebaje | Interventional Cardiology | Best Researcher Award

Posted on by Pencis

🎓Current Position:

Dr. Zaid Al-Jebaje is currently engaged in his role at Toledo Cardiology Consultants since July 2024. Prior to this, he completed his fellowship in complex, high-risk, and indicated percutaneous interventions at the Henry Ford Health System in Detroit, Michigan. This fellowship emphasized intricate coronary and peripheral interventions, chronic total occlusions, and mechanical support, reflecting his advanced skill set in interventional cardiology. His education and clinical training have equipped him with a robust foundation for delivering high-quality cardiovascular care.

📚Academic Background:

Dr. Al-Jebaje earned his MBChB from the University of Baghdad College of Medicine in Iraq (2006-2012). He completed his Internal Medicine Residency at the University at Buffalo – Catholic Health System (2016-2019) and subsequently pursued a Cardiovascular Fellowship at the University of Rochester – Strong Memorial Hospital. He further specialized with an Interventional Cardiology Fellowship at the Henry Ford Health System (2019-2023). His extensive education has provided him with the theoretical knowledge and practical skills necessary to excel in his field

📝Publication Achievements:

Dr. Al-Jebaje has an impressive publication record, contributing to over 16 peer-reviewed articles in prominent medical journals. His research covers a diverse array of topics in cardiology, including innovative techniques in transcatheter aortic valve replacement (TAVR) and the management of cardiac conditions. Some notable publications include:

  1. Outcomes following TAVR in patients with cardiogenic shock (2024) – A systematic review and meta-analysis that highlights significant findings in cardiac intervention.
  2. Retrospective Multicenter Analysis of Intravascular Lithotripsy during imaging-guided interventions, published in the Journal of Society of Cardiovascular Angiography and Intervention (2023).
  3. Liberal versus Conservative Transfusion Strategy for Patients with Acute Myocardial Infarction and Anemia (2023) – This systematic review and meta-analysis provides insights into transfusion practices.

Dr. Al-Jebaje’s dedication to research is further illustrated by his involvement in ongoing clinical trials and investigations, continually striving to advance the field of cardiology.

 

🔬Ongoing Research and Research Interests:

Dr. Al-Jebaje’s ongoing research focuses on the efficacy of new interventional techniques and the optimization of patient outcomes in complex cardiac scenarios. His specific interests include:

  • Complex Coronary Interventions: Investigating the best practices for treating patients with chronic total occlusions.
  • Transcatheter Therapies: Exploring advancements in minimally invasive procedures to improve cardiac health.
  • Cardiogenic Shock Management: Evaluating innovative strategies in treating patients experiencing severe heart failure.

These areas reflect his commitment to enhancing the understanding and treatment of cardiovascular diseases, aiming for improved patient care and outcomes.

🤝Professional Associations:

He is an active member of several professional organizations in the field of cardiology, which provide him with platforms for collaboration, continuing education, and sharing advancements in cardiac care. These associations include:

  • American College of Cardiology (ACC)
  • Society for Cardiovascular Angiography and Interventions (SCAI)

These memberships enable him to stay updated on the latest clinical guidelines and innovations in cardiovascular medicine.

🏆Awards and Scholarships 

Throughout his educational journey, Dr. Al-Jebaje has been recognized for his academic excellence and research contributions. While specific awards were not listed, his multiple certifications from the American Board of Interventional Cardiology and other specialties underscore his commitment to lifelong learning and professional development.

🎤Oral Presentations:

He has also delivered several oral presentations at notable conferences, including the SCAISHOCK Conference in Minneapolis (October 2022), where he presented his work on TransCaval LAVA ECMO in cardiogenic shock. Such presentations highlight his role as a thought leader in cardiology, sharing insights and findings with peers in the medical community.

🎓Training & Workshops 

Dr. Al-Jebaje frequently participates in workshops and training sessions to refine his skills and keep abreast of the latest techniques in interventional cardiology. This commitment to ongoing education is essential in a rapidly evolving field like cardiology.

🧪Laboratory Experience and Success Factors:

His extensive publications reflect not only his research proficiency but also his laboratory experience, where he has developed a deep understanding of cardiac physiology and intervention techniques. He is committed to translating his findings into clinical practice, aiming for better outcomes in patient care.

Dr. Al-Jebaje attributes his success to a combination of factors:

  • Dedication to Patient Care: Always prioritizing the well-being of his patients.
  • Continuous Learning: Actively engaging in professional development to enhance his skills.
  • Collaboration: Working alongside leading professionals in cardiology to foster innovation.

🛠️Tasks Completed as a Researcher:

As a researcher, Dr. Al-Jebaje has successfully managed various projects, from clinical trials to meta-analyses, contributing to the advancement of cardiovascular knowledge. His ability to work collaboratively within multidisciplinary teams has led to significant findings that influence clinical practice.

 

🌍Conclusion:

In summary, Dr. Zaid Al-Jebaje stands out as a dedicated interventional cardiologist with a wealth of knowledge and experience in complex cardiovascular interventions. His ongoing research, extensive publication record, and commitment to professional development underscore his influence in the field of cardiology. With a focus on improving patient outcomes and advancing cardiac care, he continues to be a vital contributor to medical science and the healthcare community.

 

Top Notable Publications:
  • Article Title: Galectin-3 Predicts Long-Term Risk of Cerebral Disability and Mortality in Out-of-Hospital Cardiac Arrest Survivors
    Authors: Abdelradi, A., Mosleh, W., Kattel, S., Pokharel, S., Sharma, U.C.
    Journal: Journal of Personalized Medicine
    Year: 2024
    Volume: 14
    Issue: 9
    Article Number: 994
    Citations: 0
  • Article Title: Retrospective Multicenter Analysis of Intravascular Lithotripsy Use During Calcified Left Main Coronary Artery Percutaneous Coronary Interventions
    Authors: Riley, R.F., Miller, L.E., Davies, R., Dakroub, A., Ali, Z.A.
    Journal: Journal of the Society for Cardiovascular Angiography and Interventions
    Year: 2024
    Volume: 3
    Issue: 2
    Article Number: 101213
    Citations: 1
  • Article Title: Outcomes following TAVR in patients with cardiogenic shock: A systematic review and meta-analysis
    Authors: Jabri, A., Ayyad, M., Albandak, M., AlQarqaz, M., Villablanca, P.
    Journal: Cardiovascular Revascularization Medicine
    Year: 2024
    Citations: 0
  • Article Title: Galectin-3 as a risk predictor of mortality in survivors of out-of-hospital cardiac arrest
    Authors: Mosleh, W., Kattel, S., Bhatt, H., Chaudhari, M.R., Sharma, U.C.
    Journal: Circulation: Arrhythmia and Electrophysiology
    Year: 2019
    Volume: 12
    Issue: 10
    Article Number: e007519
    Citations: 6
  • Article Title: Spinal tophaceous gout presenting in a young adult without pain
    Authors: Al-Jebaje, Z., Elibol, J.M., Peters, J., Alameri, A.
    Journal: BMJ Case Reports
    Year: 2018
    Article Number: 224406
    Citations: 5

 

Jihong Hu | Hypertension | Best Researcher Award 

Posted on by Pencis

🎓Current Position and Research Focus:

Dr. Hu holds a position at a respected institution where they continue to contribute significantly to the fields of preventive medicine and public health. Their ongoing research focuses on areas such as hypertension, cardiovascular risk assessment, and traditional Chinese medicine applications for chronic disease prevention. Through innovative studies and applied clinical work, Dr. Hu aims to enhance understanding of disease mechanisms and contribute to the development of preventive strategies in both Western and traditional Chinese medicine.

📚Academic Background:

Dr. Hu began their academic journey at Ningxia Medical University, earning a master’s degree in preventive medicine in 2000. Subsequently, they completed an undergraduate degree in the same field, graduating in 2003. Driven by a passion for epidemiology and health statistics, Dr. Hu went on to earn a doctorate from Peking Union Medical College in 2007. These degrees laid a solid foundation for a career devoted to advancing preventive medicine in both academic and clinical settings.

📝Publications and Scientific Achievements:

Over the last five years, Dr. Hu has contributed numerous papers to prestigious journals, often as the first author or corresponding author. Notable publications include research on:

  • Salt sensitivity and hypertension, investigating how salt substitutes impact blood pressure across different age groups.
  • PD-L1 expression in colorectal cancer, where Dr. Hu’s analysis provided insights into prognostic factors.
  • Gut microbiome research, exploring its association with diseases like obesity and hypertension.

These publications highlight Dr. Hu's versatility in addressing a wide range of health issues, often using meta-analyses to consolidate knowledge across studies.

🔬Ongoing Research Projects:

Dr. Hu actively participates in numerous research projects, often funded by prestigious bodies like the National Natural Science Foundation of China. Current projects include:

  • Internet+Chinese Medicine Integration: Investigating the role of Chinese medicine in preventing and controlling chronic diseases through technology.
  • Pediatric Intestinal Microecology: Examining how gut health affects respiratory infections in children.
  • Lumbar Disc Herniation Therapy: Standardizing Chinese medicine treatments for lumbar issues, focusing on Gansu’s regional medical practices.
  • Stroke and Traditional Medicine: Studying ischemic stroke through a traditional Chinese medicine perspective and assessing its diagnostic value.

These projects underscore Dr. Hu’s dedication to combining traditional Chinese medicine with modern epidemiology, aiming to offer holistic health solutions.

🔍Research Interests:

Dr. Hu’s research interests cover an impressive range within public health and epidemiology. Key areas include:

  • Chronic disease management with a particular focus on hypertension and cardiovascular risk.
  • The role of environmental and epigenetic factors in disease, particularly cardiovascular disease.
  • Traditional Chinese medicine and its integration with modern public health strategies to combat chronic illnesses.

Dr. Hu's diverse research portfolio reflects a commitment to improving population health through innovative, cross-disciplinary approaches.

🏆Awards and Scholarships:

Throughout their career, Dr. Hu has received several awards and scholarships recognizing their contributions to public health and epidemiology. While specific awards were not mentioned, it's clear from their impressive body of work that they are a valued researcher in China’s medical community.

🎤Professional Associations and Presentations:

Dr. Hu is an active member of various professional associations within the fields of preventive medicine and public health. Dr. Hu has also delivered several oral presentations at conferences and academic forums, sharing insights from studies on hypertension, cardiovascular health, and public health interventions.

🎓Training & Workshops: 

To stay updated in their field, Dr. Hu participates in training programs and workshops, often centered around epidemiological methods and data analysis. These workshops have likely included training on statistical software, meta-analysis techniques, and advanced bioinformatics relevant to health research.

🧪Laboratory Experience and Success Factors: 

Dr. Hu has extensive experience in laboratory-based research, having worked on projects involving stem cell transplantation, cytokine analysis, and cardiovascular biomarkers. Success in this domain can be attributed to strong analytical skills, dedication, and the ability to apply multi-disciplinary methods to complex health issues.

🛠️Tasks Completed as a Researcher:

Dr. Hu’s responsibilities have included:

  • Conducting data collection and statistical analysis on health data.
  • Leading clinical trials on new treatments and interventions.
  • Collaborating with traditional Chinese medicine experts to develop integrated health strategies.
  • Supervising junior researchers and contributing to project planning.

These tasks demonstrate Dr. Hu’s role as a key contributor to both team-based research and individual projects.

Citations:

Citations  201

h-index  5

i10-index  4

🌍Conclusion: 

Dr. Jihong Hu’s career reflects a deep commitment to advancing preventive medicine and public health in China. Through ongoing projects, publications, and a dedication to both epidemiology and traditional medicine, Dr. Hu bridges ancient practices with modern science. Their work not only contributes to medical knowledge but also to improved health outcomes across populations. With a track record of impactful research and a forward-thinking approach, Dr. Hu continues to lead in the integrated field of preventive medicine and epidemiology.

Top Notable Publications:

Hu, J.-H., Wang, S.-X., Wang, Y., ... Wang, L., Zhang, J. (2024). Association between salt sensitivity of blood pressure and dietary habits in survey population: A case-control study. Clinical Nutrition ESPEN, 64, 229–235.

Jin, L., Fang, S., Nan, Y., Hu, J., Jin, H. (2024). The effect of air pollutants on COPD-hospitalized patients in Lanzhou, China (2015–2019). Frontiers in Public Health, 12, 1399662.

Wang, L., Hu, J. (2024). Unraveling the gut microbiota's role in salt-sensitive hypertension: current evidences and future directions. Frontiers in Cardiovascular Medicine, 11, 1410623.

Lei, R., Zhang, L., Liu, X., ... Ren, Z., Luo, B. (2024). Residential greenspace and blood lipids in an essential hypertension population: Mediation through PM2.5 and chemical constituents. Environmental Research, 240, 117418.

Xiao, Y., Liu, C., Lei, R., ... Hu, J., Luo, B. (2023). Associations of PM2.5 composition and green space with metabolic syndrome in a Chinese essential hypertensive population. Chemosphere, 343, 140243.

Wang, S., Hu, J., Dong, G., ... Chen, X., Ding, F. (2023). Effects of bone marrow cells transplantation for acute myocardial infarction on cardiac function, infarct size, and clinical events: A meta-analysis. Chinese Medical Journal, 136(20), 2518–2520.

Zhou, E., Lei, R., Tian, X., ... Luo, B., Hu, J. (2023). Association between salt sensitivity of blood pressure and the risk of hypertension in a Chinese Tibetan population. Journal of Clinical Hypertension, 25(5), 453–462.

Hu, J., Thompson, B., Wang, S., ... Cao, Z., Wang, J. (2022). Rate and risk factors of metabolic components and component combinations according to hypertension status in Tibetans in a cross-sectional study. Medicine (United States), 101(43), E31320.

Lei, R., Wang, Z., Wang, X., ... Zhang, K., Bin Luo (2022). Effects of long-term exposure to PM2.5 and chemical constituents on blood lipids in an essential hypertensive population: A multi-city study in China. Ecotoxicology and Environmental Safety, 242, 113867.

Li, M.-Y., Wang, S.-X., Liu, X.-B., ... Cao, J., Hu, J.-H. (2021). Comparative study on the mortality rate of children under 5 years old between China and Russia from 1990 to 2017. Zhongguo Ertong Baojian Zazhi, 29(9), 1021–1025.

Yazan Otoum | Heart Disease | Best Researcher Award

Posted on by Pencis
Education:

Dr. Yazan Otoum holds a Ph.D. in Electrical and Computer Engineering from the University of Ottawa, Canada, where he focused on developing AI-based intrusion detection systems to enhance the security of the Internet of Things (IoT). He earned his M.Sc. in Networks Engineering and Management from DePaul University in the USA in 2009 and a B.Sc. in Software Engineering from Philadelphia University in Jordan in 2006. Dr. Otoum’s diverse educational background equips him with a robust understanding of network security, software development, and emerging technologies, allowing him to contribute significantly to research and teaching in his field.

Professional Experience:

 

Dr. Yazan Otoum is an Assistant Professor of Cybersecurity at Algoma University in Brampton, Ontario, Canada, since 2024. He teaches graduate courses such as Data Structures I, Data Structures II, and Introduction to Cybersecurity. Prior to this, he was a part-time professor at the University of Ottawa and Algonquin College, where he instructed courses in data structures, algorithms, and digital forensics. Dr. Otoum has a solid background in research and teaching, having guided master’s students in developing security frameworks focused on IoT and Federated Learning during his tenure as a Research Assistant at the University of Ottawa. Previously, he was a lecturer at Majmaah University in Saudi Arabia, where he initiated the “Digital Citizenship” project under Saudi Vision 2030, enhancing digital literacy and responsible technology use. His early career included significant roles in system administration for educational projects in Jordan, where he managed platforms serving over 2 million users and led efforts in disaster recovery and cybersecurity analysis.

 

Honours and Awards:

 

Dr. Yazan Otoum has received several accolades for his contributions to cybersecurity education and community engagement. In 2023, he was awarded the Cybersecurity Career Mentor Badge by the EC-Council, recognizing his efforts in mentoring aspiring cybersecurity professionals. He also earned the Cisco Instructor 5 Years of Service Badge in 2019 for his impactful teaching in the Cisco Networking Academy. Notably, in 2018, he received an Award and Certificate of Appreciation from “Saudi Vision 2030” for his role in the “Digital Citizenship” project, which won the best project award. His other recognitions include multiple certificates of appreciation from Majma’ah University for his significant contributions to ABET accreditation, organizing a nationwide robotics competition, and conducting a national cybersecurity boot camp. Additionally, he was acknowledged by the University of Jadara in 2011 for delivering an impactful presentation on eLearning in education.

Graduate Co-Supervision:

Dr. Yazan Otoum has supervised several innovative research projects in the field of cybersecurity and healthcare technology. In 2023, he guided Pratish Pushparaj in developing an Intrusion Detection System Model using LLaMA 2 with generative dataset augmentation. Chaosheng Hu’s project focused on heart disease prediction through federated learning and blockchain integration, while Siddhant Tiwari explored a differential privacy-driven framework for enhancing heart disease prediction. Navya Gottimukkala investigated the application of machine learning in metaverse security. Earlier, in the 2022-2023 academic year, Paritosh Singh worked on deep collaborative learning for robust healthcare security. Dr. Otoum also supervised Yue Wan’s research on a federated transfer learning-based IDS for the Internet of Medical Things (IoMT) and Sai Yadlapalli’s framework for securing IoT through federated transfer learning during the 2020-2021 academic year.

Graduate Courses:

Dr. Yazan Otoum’s teaching portfolio includes advanced topics in cybersecurity, focusing on the integration of machine learning and artificial intelligence for practical applications. He covers wireless ad-hoc networking and the innovative frameworks of software-defined networks (SDN) and cloud computing, which are essential for modern network management. Additionally, his courses explore multimedia communication, emphasizing the importance of secure data transmission in diverse formats. Dr. Otoum also introduces students to deep learning (DL) and reinforcement learning (RL), equipping them with the skills needed to leverage these cutting-edge technologies in cybersecurity.

Conclusion:

Dr. Yazan Otoum’s extensive experience in cybersecurity education, research, and practical applications positions him as a pivotal figure in shaping the next generation of cybersecurity professionals. His commitment to integrating advanced technologies such as machine learning, blockchain, and cloud computing into his curriculum reflects a forward-thinking approach to education. Through his mentorship and innovative teaching methods, Dr. Otoum not only imparts critical knowledge but also inspires students to tackle emerging challenges in the field. His contributions to projects like “Digital Citizenship” under the Saudi Vision 2030 initiative and recognition from prestigious organizations further underscore his dedication to enhancing cybersecurity awareness and education globally. As he continues to lead initiatives and mentor future experts, Dr. Otoum plays a crucial role in advancing cybersecurity practices and fostering a secure digital environment.

Top Notable Publications:

Enhancing Heart Disease Prediction with Federated Learning and Blockchain Integration

Authors: Chaosheng Hu, Yazan Otoum, et al.

Year: 2024

Journal: Future Internet

DOI: 10.3390/fi16100372

Machine Learning in Metaverse Security: Current Solutions and Future Challenges

Authors: Yazan Otoum, et al.

Year: 2024

Journal: ACM Computing Surveys

DOI: 10.1145/3654663

DL-IDS: a deep learning–based intrusion detection framework for securing IoT

Authors: Yazan Otoum, et al.

Year: 2022

Journal: Transactions on Emerging Telecommunications Technologies

DOI: 10.1002/ett.3803

FTLIoT: A Federated Transfer Learning Framework for Securing IoT

Authors: Yazan Otoum, et al.

Year: 2022

Conference: IEEE Global Communications Conference

DOI: 10.1109/GLOBECOM48099.2022.10001461

WOSUID: WOS:000922633501029

Transfer Learning-Driven Intrusion Detection for Internet of Vehicles (IoV)

Authors: Yazan Otoum, et al.

Year: 2022

Conference: International Wireless Communications and Mobile Computing Conference

DOI: 10.1109/IWCMC55113.2022.9825115

WOSUID: WOS:001058917600060

AS-IDS: Anomaly and Signature Based IDS for the Internet of Things

Authors: Yazan Otoum, et al.

Year: 2021

Journal: Journal of Network and Systems Management

DOI: 10.1007/s10922-021-09589-6

On securing IoT from Deep Learning perspective

Authors: Yazan Otoum, et al.

Year: 2021

ISBN: 978-1-7281-8087-8

 

Aristoteles Alencar Neto | Amyloidosis | Excellence in Research

Posted on by Pencis
Dr. Aristoteles Alencar Neto, PMAM, Brazil

Dr. Aristoteles Alencar Neto is a cardiologist from PMAM, Brazil, with specialized training in echocardiography, cardiology, and internal medicine. He completed his medical residency at prestigious institutions such as the Hospital das Clínicas at the University of São Paulo and Santa Casa de Misericórdia de São Paulo. His research focuses on cardiovascular health, including myocardial stiffness and aortic valve treatment, with several publications in leading cardiology conferences. Dr. Alencar is also known for his work in Libman-Sacks endocarditis and antiphospholipid syndrome.

Profile:
Education:

Dr. Aristoteles Alencar Neto is a highly trained cardiologist from Brazil, with a strong educational background in medical residency. He completed his specialization in echocardiography (2018-2020) and cardiology (2016-2018) at the prestigious Hospital das Clínicas, University of São Paulo (FMUSP). Additionally, he specialized in internal medicine (2013-2015) at Santa Casa de Misericórdia de São Paulo. Dr. Alencar Neto earned his medical degree from the Federal University of Amazonas (UFAM) in 2013. His expertise spans cardiology and clinical medicine, with a focus on human health sciences.

Complementary Education:

Dr. Aristoteles Alencar Neto has pursued extensive additional training to enhance his expertise in healthcare management and cardiology. In 2021-2022, he completed an MBA in Administration, specializing in the management of clinics, hospitals, and healthcare industries, from Fundação Getúlio Vargas (FGV). His cardiology-focused training includes advanced courses such as ACLS at FMUSP’s Instituto do Coração, intensive care echocardiography (ECOTIN), and international experience at Hospital Universitário de La Paz in Spain. He has also participated in various continuing education programs to stay current in emergency and cardiovascular care.

Professional Experience:

 

Dr. Aristoteles Alencar Neto has accumulated diverse professional experience in the healthcare field. Since 2020, he has been affiliated with the Instituto do Coração at Hospital das Clínicas (INCOR-FMUSP) in São Paulo, Brazil. He previously worked at Hospital Santa Isabel (2015-2016) and served at the Secretaria Municipal de Saúde de Manaus (SEMSA) from 2009 to 2011. Additionally, Dr. Alencar Neto collaborated with the Federal University of Amazonas (UFAM) between 2008 and 2011, contributing to various healthcare initiatives and research projects.

Research Projects:

Dr. Aristoteles Alencar Neto has participated in various research projects, contributing to advancements in cardiology and related health sciences. His projects have focused on critical topics like heart failure, renal insufficiency in cardiac patients, and advanced imaging techniques in cardiology. His collaborative research has been presented at national and international conferences, helping to enhance clinical practices and patient outcomes in cardiology. Additionally, his work in medical residency programs has been closely tied to academic and clinical research, enriching his contributions to the field of cardiovascular health.

Awards and Titles:

In 2011, Dr. Aristoteles Alencar Neto received an Honorable Mention for his contributions to the Institutional Health Science Research Fellowship Program (PIBIC), recognizing his dedication and excellence in scientific research during his early career in health sciences. This accolade highlights his commitment to advancing medical knowledge through research.

Activities:

Dr. Aristoteles Alencar Neto has been actively involved in several research projects between 2007 and 2011. His work includes contributing to epidemiological studies on tuberculosis and HIV co-infection, investigating hospital morbidity related to tuberculosis in Manaus, and supporting morbid obesity programs. Additionally, he participated in initiatives such as the Neurology and Neurosurgery University League of Amazonas and helped prepare anatomical collections for educational use. His research efforts have significantly contributed to the advancement of public health in the region.

Conclusion:

Dr. Aristoteles Alencar Neto has demonstrated a strong commitment to advancing medical knowledge and public health through his clinical practice, research, and education. With extensive training in cardiology, echocardiography, and internal medicine, coupled with a rich professional and academic background, he has contributed to improving patient care and the understanding of complex medical conditions. His involvement in various research projects and clinical initiatives highlights his dedication to addressing pressing health challenges, particularly in cardiology and infectious diseases, positioning him as a valuable asset to the medical community in Brazil.

Top Notable Publications:

Assessment of Right Ventricular Myocardial Stiffness by Cardiac Elastography in Patients with Transthyretin Amyloidosis

Authors: Not specified in the provided information

Year: 2025

Journal: Current Problems in Cardiology

DOI: 10.1016/j.cpcardiol.2024.102867

Papel da Elastografia por Ondas de Cisalhamento na Avaliação da Rigidez Miocárdica nas Diversas Miocardiopatias

Authors: Not specified in the provided information

Year: 2023

Journal: ABC Imagem Cardiovascular

Date: 2023-12-21

DOI: 10.36660/abcimg.20230108

Role of Shear Wave Elastography in the Assessment of Myocardial Stiffness in Various Cardiomyopathies

Authors: Not specified in the provided information

Year: 2023

Journal: ABC Imagem Cardiovascular

Date: 2023-12-20

DOI: 10.36660/abcimg.20230108i

Tratamiento quirúrgico de la válvula aórtica guiado por ecocardiografía transesofágica 3D en paciente com endocarditis de Libman-Sacks y síndrome antifosfolipídico

Authors: Not specified in the provided information

Year: 2022

Journal: Revista Argentina de Cardiología

DOI: 10.7775/rac.es.v90.i6.20580

Tratamiento quirúrgico de la válvula aórtica guiado por ecocardiografía transesofágica 3D en paciente com endocarditis de Libman-Sacks y síndrome antifosfolipídico

Authors: Not specified in the provided information

Year: 2022

Journal: Revista Argentina de Cardiología

DOI: 10.7775/rac.es.v90.i6.20574

Perfil Clínico, Laboratorial e de Métodos de Imagem na Amiloidose Sistêmica em um Centro de Referência Cardiológico Brasileiro

Authors: Not specified in the provided information

Year: 2021

Journal: Arquivos Brasileiros de Cardiologia

Date: 2021-12-20

DOI: 10.36660/abc.20201003

 

Rachad Zayat | Cardiac Surgery | Best Researcher Award

Posted on by Pencis
Assoc Prof Dr. Rachad Zayat, RWTH University Hospital Aachen, Germany

Assoc. Prof. Dr. Rachad Zayat is a highly skilled and board-certified cardiothoracic surgeon at RWTH University Hospital Aachen, Germany, with over 12 years of operating room experience. Specializing in complex procedures such as coronary artery bypass grafting (CABG), valve repair, pacemaker implantation, and transcatheter aortic valve replacement (TAVR), Dr. Zayat has performed over 450 surgeries in the past two years alone. He is proficient in mechanical circulatory support systems like ECMO and LVAD, and is also known for expertise in minimally invasive and robotic-assisted thoracic surgery. Dr. Zayat is actively involved in academia and medical research, further contributing to advancements in cardiothoracic care.

Profile:
Education:

 

Assoc. Prof. Dr. Rachad Zayat holds a Doctor of Medicine (M.D.) in Cardiac Surgery from RWTH University Hospital, Aachen, Germany, completed in May 2016. His dissertation focused on the impact of percutaneous dilatational tracheostomy on the incidence of sternal wound infections, analyzing a large dataset of 4,100 cases. He earned his German State Examination for Medicine from C.A.U University of Kiel in September 2011, following his high school education at the American College in Aleppo, Syria, where he graduated in August 2003.

Professional Experience:

 

Assoc. Prof. Dr. Rachad Zayat is a highly experienced cardiothoracic surgeon currently serving as Consultant Cardiothoracic Surgeon and Head of the Mechanical Circulatory Support Program at Heart Centre Trier. Since October 2023, he has led groundbreaking procedures, including the first Total Artificial Heart CARMAT® implantation in Rheinland-Pfalz, and developed a successful Robotic Thoracic Surgery program. From 2020 to 2023, he was a Consultant Thoracic Surgeon at RWTH University Hospital Aachen, performing numerous TAVR, CABG, and ECMO procedures while mentoring students and residents. During his cardiac surgery residency (2012-2020), Dr. Zayat gained extensive experience in complex surgeries, including over 100 CABG and 50 valve surgeries.

Research Interest:

 

Assoc. Prof. Dr. Rachad Zayat focuses his research on advancing cardiothoracic surgical techniques, with a particular interest in catheter-based heart valve therapies (TAVR), ultrasound-assisted catheter-directed thrombolysis (EKOS-Lyse) for pulmonary embolism, and mechanical circulatory support systems like ECMO and LVAD. He also explores innovations in heart failure surgery, robotic and minimally invasive thoracic surgery, and works to improve patient outcomes. Dr. Zayat actively engages in medical research, addressing challenges in cardiac surgery, and regularly publishes his findings in peer-reviewed journals.

Conclusion:

In conclusion, Assoc. Prof. Dr. Rachad Zayat stands as a distinguished figure in cardiothoracic surgery, demonstrating exceptional leadership, clinical expertise, and commitment to advancing patient care. His pioneering work in mechanical circulatory support systems, minimally invasive thoracic surgery, and groundbreaking procedures like the first-in-man Total Artificial Heart CARMAT® implantation has solidified his reputation as a leading expert in the field. Dr. Zayat’s contributions to both clinical practice and academic research continue to impact the future of cardiothoracic surgery, inspiring innovation and excellence in the medical community.

Top Notable Publications:

Hima, F., Saunders, A., Kashefi, A., Zayat, R., Kalverkamp, S. (2024). “In vitro evaluation of the performance of an oxygenator depending on the non-standard gas content of the inlet blood with special regard on CO2 elimination.” Perfusion (United Kingdom), 39(8), pp. 1614–1620.
Citations: 0

Schnoering, L., Khattab, M.A., Akhyari, P., Lotfi, S., Zayat, R. (2024). “Pressure-dimension index and left ventricular sphericity index following HeartMate II and HeartMate 3 implantation.” ESC Heart Failure, 11(5), pp. 3012–3022.
Citations: 2

Kolashov, A., Lotfi, S., Spillner, J., Zayat, R., Khattab, M.A. (2024). “Evaluation of myocardial work changes after lung resection—the significance of surgical approach: an echocardiographic comparison between VATS and thoracotomy.” General Thoracic and Cardiovascular Surgery, 72(8), pp. 542–550.
Citations: 0

Billig, S., Zayat, R., Yelenski, S., Hochhausen, N., Derwall, M. (2024). “The Self-Expandable Impella CP (ECP) as a Mechanical Resuscitation Device.” Bioengineering, 11(5), 456.
Citations: 0

Durak, K., Nubbemeyer, K., Zayat, R., Kalverkamp, S., Kersten, A. (2024). “De Ritis Ratio to Predict Clinical Outcomes of Intermediate- and High-Risk Pulmonary Embolisms.” Journal of Clinical Medicine, 13(7), 2104.
Citations: 0

Doukas, P., Dalibor, N., Keszei, A., Akhyari, P., Mehdiani, A. (2024). “Factors Associated with Early Mortality in Acute Type A Aortic Dissection—A Single-Centre Experience.” Journal of Clinical Medicine, 13(4), 1023.
Citations: 0

Abdulwahab, H.A.M., Kolashov, A., Haneya, A., Zayat, R., Khattab, M.A. (2024). “Temperature management in acute type A aortic dissection treatment: deep vs. moderate hypothermic circulatory arrest. Is colder better?” Frontiers in Cardiovascular Medicine, 11, 1447007.
Citations: 0

Hima, F., Kalverkamp, S., Kashefi, A., Spillner, J., Mouzakis, F. (2023). “Oxygenation performance assessment of an artificial lung in different central anatomic configurations.” International Journal of Artificial Organs, 46(5), pp. 295–302.
Citations: 1

Hill, A., Bergmann, D., Schulte, J., Brücken, A., Stoppe, C. (2023). “Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery.” Frontiers in Cardiovascular Medicine, 9, 1017867.
Citations: 4

Hill, A., von Dossow, V., Heyland, D.K., Moza, A., Stoppe, C. (2022). “Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device—The PROPER-LVAD Study.” Surgeries (Switzerland), 3(4), pp. 284–296.
Citations: 4

Yu Tian | Cardiac immunology | Best Researcher Award

Posted on by Pencis
Dr. Yu Tian, Jiangsu University, China

Dr. Yu Tian is a prominent researcher at Jiangsu University, China, specializing in immunology and molecular biology. With a focus on immune cell migration, viral myocarditis, and neuroinflammation, Dr. Tian has contributed significantly to understanding immune responses in cardiovascular and neurological diseases. He has published numerous articles in prestigious journals such as Journal of Leukocyte Biology and International Immunopharmacology, and his research explores therapeutic targets like HMGB1 and IL-22. Dr. Tian’s work plays a critical role in advancing treatment strategies for diseases involving immune system dysfunction and inflammation.

Profile:
Education:

 

Dr. Yu Tian completed his Bachelor’s Degree in Medicine at Qinghai University from September 2011 to June 2016. He then pursued his Master’s and Ph.D. at Jiangsu University, School of Medicine, from September 2016 to September 2022, where he specialized in immunology and molecular biology. His academic journey has laid a strong foundation for his research in immune cell function and disease mechanisms, contributing to his current role as a researcher at Jiangsu University.

Professional Experience:

 

Dr. Yu Tian is currently a researcher at Jiangsu University, School of Life Sciences, specifically within the International Genomics Research Center, a position he has held since December 2022. In this role, he leads a horizontal research project investigating the effects of HMGB1 on immune cells, which commenced in 2023. Additionally, Dr. Tian is actively involved in a National Natural Science Foundation of China (NSFC)-funded project that examines the role of IGF-1 in heart damage following myocardial infarction, scheduled for 2025 to 2027. His work contributes significantly to advancing the understanding of immune mechanisms in cardiovascular health.

 

Research Interest:

 

Dr. Yu Tian’s research interests lie in immunology, specifically investigating the role of HMGB1 in immune cell responses. He focuses on cardiovascular diseases, exploring the mechanisms that contribute to heart damage and myocardial infarction. Additionally, Dr. Tian studies adipose tissue accumulation and its impact on worsening heart conditions, aiming to uncover potential therapeutic targets for improving cardiovascular health. His work seeks to enhance the understanding of immune and metabolic interactions in the context of heart disease.

Conclusion:

Dr. Yu Tian is an accomplished researcher at Jiangsu University, specializing in immunology and cardiovascular diseases. With a solid educational background and a focus on the role of HMGB1 in immune responses, he is dedicated to unraveling the complex mechanisms underlying heart damage and myocardial infarction. His ongoing research projects aim to deepen the understanding of immune cell interactions and metabolic factors that exacerbate cardiovascular conditions. Through his contributions, Dr. Tian is poised to make a significant impact on the field, advancing potential therapeutic strategies for improving heart health and addressing related diseases.

Top Notable Publications:

Yin, P., Su, Z., Shu, X., Dong, Z., Tian, Y. (2024). Role of TREM2 in immune and neurological diseases: Structure, function, and implications. International Immunopharmacology, 143, 113286. 0 citations

Tian, Y., Gong, X., Qin, D., Liu, F., Su, Z. (2023). S1PR1-dependent migration of ILC3s from intestinal tissue to the heart in a mouse model of viral myocarditis. Journal of Leukocyte Biology, 114(2), 154–163. 7 citations

Tian, Y., Chen, R., Su, Z. (2023). HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson’s Disease. Cellular and Molecular Neurobiology, 43(1), 47–58. 6 citations

Chen, R., Liu, F., Xia, L., Xu, H., Su, Z. (2022). B10 cells decrease fibrosis progression following cardiac injury partially by IL-10 production and regulating hyaluronan secretion. Journal of Leukocyte Biology, 111(2), 415–425. 1 citation

Cao, Y., Tian, Y., Liu, Y., Su, Z. (2022). Reg3β: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders. International Reviews of Immunology, 41(2), 160–170. 2 citations

Che, Y., Tian, Y., Chen, R., Liu, F., Su, Z. (2021). IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C. Biochimica et Biophysica Acta – Molecular Basis of Disease, 1867(9), 166171. 26 citations

Chen, W., Yao, S., Wan, J., Yao, Y., Zhang, X. (2021). BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. Journal of Controlled Release, 333, 129–138. 45 citations

Li, J., Xia, L., Liu, F., Chen, R., Su, Z. (2021). lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPβ-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs. Clinical and Translational Medicine, 11(5), e407. 1 citation

Huang, L., Wan, J., Wu, Y., Su, Z., Xu, H. (2021). Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. Life Sciences, 270, 119142. 26 citations

Wan, J., Wu, Y., Huang, L., Wang, S., Xu, H. (2021). ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells. Cancer Letters, 502, 34–43. 31 citations

 

 

Chunyan Gao | Thrombosis | Best Researcher Award

Posted on by Pencis
Dr. Chunyan Gao, Harbin Medical University-Daqing, China

Dr. Chunyan Gao is a distinguished medical professional and researcher at Harbin Medical University-Daqing, China. She holds extensive expertise in her field, contributing to medical education and research with a focus on public health and medical sciences. Dr. Gao has published numerous scholarly articles and actively participates in both national and international research collaborations, reflecting her dedication to advancing medical knowledge and improving healthcare outcomes. Her work is particularly recognized for its impact on community health initiatives and academic excellence.

Profile:
Orcid Profile

Education:

Dr. Chunyan Gao completed her Ph.D. at Harbin Medical University, China, from 2010 to 2013, following her M.S. degree from the same university between 2004 and 2007. She earned her B.S. from Jiamusi University, China, in 2001. Dr. Gao’s educational background reflects a strong foundation in medical sciences, contributing to her expertise and research endeavors in the field.

Professional Experience:

Dr. Chunyan Gao has had a distinguished academic career at Harbin Medical University-Daqing, where she has held several key positions since 2001. She began as a Teaching Assistant in the Department of Medical Laboratory Science and Technology from 2001 to 2006, then became a Lecturer from 2006 to 2011. Dr. Gao was promoted to Associate Professor from 2011 to 2015 and has served as a Professor in the same department since 2015. Additionally, she was a Visiting Scholar at the Blood Research Institute, Versiti Wisconsin, in Milwaukee, WI, from 2015 to 2018. Her extensive experience in education and research underscores her commitment to advancing the field of medical laboratory science.

Research and Innovations:

Dr. Chunyan Gao, MD, PhD, is a leading researcher at Harbin Medical University-Daqing, China, focusing on thrombosis and hemostasis. Currently, she serves as the Principal Investigator for several high-profile projects, including a National Natural Science Foundation of China grant (Project No. 82270134, 2023-2026). Dr. Gao has successfully completed various significant projects, such as Project No. 82070140 (2021-2024) and Project No. 81400097 (2015-2017) under the same foundation. Her portfolio also includes the Marshal Initiative Funding (HMUMIF-22005, 2022-2023) and multiple other provincial and institutional grants, showcasing her substantial contributions to advancing research in her field.

Conclusion:

In conclusion, Dr. Chunyan Gao’s extensive research in thrombosis and hemostasis has positioned her as a prominent figure in her field. Through her leadership as Principal Investigator on numerous prestigious projects, including those funded by the National Natural Science Foundation of China and various provincial initiatives, she continues to drive significant advancements in medical science. Her ongoing work not only enhances our understanding of critical health issues but also paves the way for innovative treatments and interventions, reflecting her commitment to improving patient outcomes in the area of vascular health.

Top Notable Publications:

Yan, M., Wang, Z., An, Y., … Wang, D., Gao, C. (2024). OxLDL enhances procoagulant activity of endothelial cells by TMEM16F-mediated phosphatidylserine exposure. Cell Biology International, 48(6), pp. 848–860.

Li, Z., Yan, M., Wang, Z., … Wang, L., Gao, C. (2022). Ferroptosis of Endothelial Cells Triggered by Erythrophagocytosis Contributes to Thrombogenesis in Uremia. Thrombosis and Haemostasis, 123(12), pp. 1116–1128.

Yan, M., Xu, M., Li, Z., … Shi, J., Gao, C. (2022). TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia. Blood Cells, Molecules, and Diseases, 96, 102666.

Yu, H., Wang, Z., Li, Z., … Shi, J., Gao, C. (2021). Hyperuricemia enhances procoagulant activity of vascular endothelial cells through TMEM16F regulated phosphatidylserine exposure and microparticle release. FASEB Journal, 35(9), e21808.

Chen, Y., Schroeder, J.A., Gao, C., … Hu, J., Shi, Q. (2021). In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapy. Journal of Cellular Physiology, 236(1), pp. 354–365.

Ji, S., Dong, W., Qi, Y., … Shi, J., Gao, C. (2020). Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro. Journal of Thrombosis and Haemostasis, 18(1), pp. 222–233.

Gao, C., Schroeder, J.A., Xue, F., … Czechowicz, A., Shi, Q. (2019). Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. Blood Advances, 3(18), pp. 2700–2711.

Ma, R., Xie, R., Yu, C., … Zhou, J., Shi, J. (2018). Erratum: Publisher Correction: Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis. Scientific Reports, 8(1), pp. 6224.

Ma, R., Xie, R., Yu, C., … Zhou, J., Shi, J. (2017). Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis. Scientific Reports, 7(1), 4978.

Gao, C., Xie, R., Yu, C., … Zhou, J., Shi, J. (2015). Thrombotic role of blood and endothelial cells in uremia through phosphatidylserine exposure and microparticle release. PLoS ONE, 10(11), e0142835.